Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 3 min ago
PreprintCC BY-NC-NDbioRxiv

Alcohol, Tobacco, and HPV exposure synergistically regulate promoter methylation of PD-L1 related genes in Head and Neck Squamous Cell Carcinoma

  1. 1UNIVERSITY OF CALIFORNIA, SAN DIEGO

Abstract

Although alcohol, tobacco and human papillomavirus (HPV) are established risk factors for head and neck squamous cell carcinoma (HNSCC), the molecular effects of their co-occurrence remain poorly understood. DNA methylation may link exposure history to regulation of the PD-1/PD-L1 immune checkpoint pathway, whose therapeutic blockade benefits only a subset of patients with recurrent or metastatic HNSCC. We stratified primary tumors from The Cancer Genome Atlas HNSCC cohort by all combinations of these exposures and examined promoter methylation across seven interferon-{gamma}-PD-L1 signaling genes at single-CpG resolution, with region-level validation. Triple-exposure tumors exhibited coordinated methylation changes involving CD274, IRF1, JAK1, PDCD1, MIR33A and MIR34A, with differentially methylated regions overlapping PDCD1, MIR34AHG and JAK1. CD274 promoter methylation is inversely correlated with gene expression. Significant methylation differences occurred only in HPV-positive subgroups, suggesting HPV may be necessary for this phenotype, while concurrent exposures may modify its extent. Transcriptomic analysis and immune deconvolution further suggested greater estimated immune infiltration alongside downregulation of innate and adaptive immune activation pathways, consistent with an inflamed but functionally suppressed tumor microenvironment. These findings suggest combined exposure history may help contextualize checkpoint pathway regulation in HNSCC.

Related

  1. RNF152 promoter methylation and gene expression in oral premalignant lesions and oral squamous cell carcinoma: implications for epigenetic biomarker development
    Madona Gjona, Seval Turna, Cömert Şen +6
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  2. TGF‐β1 Induced Methylation to Regulate SOCS3 Expression in Abnormal Activation of Vocal Fold Fibroblasts
    Hai‐Zhou Wang, An‐Qi Zhao, Xue‐Yan Li +2
    World journal of otorhinolaryngology - head and neck surgeryPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Nuclear estrogen receptors differentially regulate the cyp19a1a promoter in Trachinotus blochii
    Chen-Hao Hu, Qian Liu, Yi-Ling Liu +6
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
  4. Polycomb Marked Promoter Methylation Gains in Aging and Cancer are Independent of Replication
    H. Easwaran, S.-J. Thursby, N. Patel +11
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  5. Folic Acid Oversupplementation Alters Global DNA Methylation and Circadian Clock Gene Expression in FaDu Head and Neck Squamous Cell Carcinoma Cells: An Exploratory Study
    Negin Faramarzi Garous, Liubov Lobanova, Silvana Papagerakis +3
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
BibTeX
@misc{mokhashi2026alcohol,
  title = {{Alcohol, Tobacco, and HPV exposure synergistically regulate promoter methylation of PD-L1 related genes in Head and Neck Squamous Cell Carcinoma}},
  author = {O. M. Mokhashi and L. Gao and R. Xin and R. Chhabra and S. Hale and W. M. Ongkeko},
  howpublished = {bioRxiv},
  year = {2026},
  month = may,
  doi = {10.64898/2026.05.26.728017},
  url = {https://www.biorxiv.org/content/10.64898/2026.05.26.728017v2},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Alcohol, Tobacco, and HPV exposure synergistically regulate promoter methylation of PD-L1 related genes in Head and Neck Squamous Cell Carcinoma
AU  - O. M. Mokhashi
AU  - L. Gao
AU  - R. Xin
AU  - R. Chhabra
AU  - S. Hale
AU  - W. M. Ongkeko
PY  - 2026
DA  - 2026/05/26
PB  - bioRxiv
DO  - 10.64898/2026.05.26.728017
UR  - https://www.biorxiv.org/content/10.64898/2026.05.26.728017v2
AB  - Although alcohol, tobacco and human papillomavirus (HPV) are established risk factors for head and neck squamous cell carcinoma (HNSCC), the molecular effects of their co-occurrence remain poorly understood. DNA methylation may link exposure history to regulation of the PD-1/PD-L1 immune checkpoint pathway, whose therapeutic blockade benefits only a subset of patients with recurrent or metastatic HNSCC. We stratified primary tumors from The Cancer Genome Atlas HNSCC cohort by all combinations of these exposures and examined promoter methylation across seven interferon-{gamma}-PD-L1 signaling genes at single-CpG resolution, with region-level validation. Triple-exposure tumors exhibited coordinated methylation changes involving CD274, IRF1, JAK1, PDCD1, MIR33A and MIR34A, with differentially methylated regions overlapping PDCD1, MIR34AHG and JAK1. CD274 promoter methylation is inversely correlated with gene expression. Significant methylation differences occurred only in HPV-positive subgroups, suggesting HPV may be necessary for this phenotype, while concurrent exposures may modify its extent. Transcriptomic analysis and immune deconvolution further suggested greater estimated immune infiltration alongside downregulation of innate and adaptive immune activation pathways, consistent with an inflamed but functionally suppressed tumor microenvironment. These findings suggest combined exposure history may help contextualize checkpoint pathway regulation in HNSCC.
ER  -